Suspected percutaneous tricuspid bioprosthesis dysfunction: cardiac CT gives us the keys

Authors

  • Juan Diego Sánchez Vega Cardiology Department, University of Navarra Clinic. Madrid. Spain. https://orcid.org/0000-0003-1541-2895
  • María Fernanda León Blanchet Cardiology Department, Álvaro Cunqueiro Hospital. Vigo. Spain https://orcid.org/0000-0002-9285-8391
  • Pablo Pazos Díaz Cardiology Department, Álvaro Cunqueiro Hospital. Vigo. Spain
  • Francisco Calvo Iglesias Cardiology Department, Álvaro Cunqueiro Hospital. Vigo. Spain https://orcid.org/0000-0002-3235-3658
  • José Antonio Parada Barcía Cardiology Department, Álvaro Cunqueiro Hospital. Vigo. Spain
  • Manuel Barreiro Pérez Cardiology Department, Álvaro Cunqueiro Hospital. Vigo. Spain https://orcid.org/0000-0001-7489-2935

DOI:

https://doi.org/10.37615/retic.v8n2a8

Keywords:

ricuspid percutaneous prosthesis, HALT, RELM

Abstract

Percutaneous treatment of tricuspid regurgitation has been one of the great advances in interventional cardiology in recent years. Imaging follow-up of these patients is usually performed by transthoracic echocardiography. However, if prosthetic dysfunction is suspected, a CT study can give us the keys to adequate analysis. We present the clinical case of a percutaneous tricuspid prosthesis in which 4D cardiac CT allowed us to establish the diagnosis of subclinical thrombosis of the leaflets, and to prescribe the medical treatment previous to a greater degree of prosthetic dysfunction.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Karady J, Apor A, Nagy A, et al. Quantification of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation: clinical relevance of hypo-attenuated leaflet thickening volume. Eur Heart J Cardiovasc Imaging. 2020;21(6):715-724. https://doi.org/10.1093/ehjci/jeaa184 DOI: https://doi.org/10.1093/ehjci/jeaa184

Yanagisawa R, Tanaka M, Yashima F, Arai T, Shirai S, Shimizu H, et al. Early and late leaflet thrombosis after transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2019;12(5):e007349. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007349 DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.118.007349

Blanke P, Leipsic J, Popma JJ, Yakubov SJ, Deeb GM, Gada H, et al. Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study. J Am Coll Cardiol. 2020;75(19):2430-2442. https://doi.org/10.1016/j.jacc.2020.03.022 DOI: https://doi.org/10.1016/j.jacc.2020.03.022

Moscarelli M, Prestera R, Pernice V, et al. Subclinical Leaflet Thrombosis Following Surgical and Transcatheter Aortic Valve Replacement: A Meta-Analysis. Am J Cardiol. 2023; 204:171-177 https://doi.org/10.1016/j.amjcard.2023.07.089 DOI: https://doi.org/10.1016/j.amjcard.2023.07.089

Tabrizi N, Fishberger G, Musuku S, et al. Hypoattenuated Leaflet Thickening: A Comprehensive Review of Contemporary Data. J Cardiothorac Vasc Anesth. 2024; 38(11):2761-2769. https://doi.org/10.1053/j.jvca.2024.06.043 DOI: https://doi.org/10.1053/j.jvca.2024.06.043

Published

2025-08-26

How to Cite

1.
Sánchez Vega JD, León Blanchet MF, Pazos Díaz P, Calvo Iglesias F, Parada Barcía JA, Barreiro Pérez M. Suspected percutaneous tricuspid bioprosthesis dysfunction: cardiac CT gives us the keys. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2025 Aug. 26 [cited 2025 Sep. 3];8(2):33-6. Available from: https://imagenretic.org/RevEcocarPract/article/view/705

Most read articles by the same author(s)